Mahkam Zanganeh - 20 May 2021 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director
Signature
/s/ Sandra Gardiner, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
20 May 2021
Net transactions value
$0
Form type
4
Filing time
21 May 2021, 17:09:15 UTC
Previous filing
14 May 2021
Next filing
17 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 20 May 2021 Common Stock 20,000 $18.69 Direct F1
transaction PLSE Stock Option (right to buy) Award $0 +8,026 $0.000000 8,026 20 May 2021 Common Stock 8,026 $18.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date.
F2 The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date.